ARTHEx Appoints Christian Freitag Chief Medical Officer

Company ARTHEx Biotech Event Type Leadership appointment Modality RNA therapeutic Asset ATX-01 Target DMPK CTG-repeat RNA Disease Area Myotonic dystrophy type 1 Summary ARTHEx Biotech announced on November 4 that Christian Freitag has been appointed chief medical officer as its RNA therapeutic ATX-01 advances in…